# Hisanori Umehara

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hisanori-umehara/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,760 |
| Field | IgG4-Related and Inflammatory Diseases |
| h-index | 62 |
| i10-index | 146 |
| Last Known Institution | Nagahama City Hospital |
| OpenAlex ID | https://openalex.org/A5014411218 |
| ORCID iD | 0000-0001-9833-4647 |
| Works | 227 |

## Researcher papers

Showing 12 of 17.

- [Consensus statement on the pathology of IgG4-related disease](https://scholariq.org/papers/consensus-statement-on-the-pathology-of-igg4-related-disease/)
- [Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011](https://scholariq.org/papers/comprehensive-diagnostic-criteria-for-igg4-related-disease-igg4-rd-2011/)
- [Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011](https://scholariq.org/papers/comprehensive-diagnostic-criteria-for-igg4-related-disease-igg4-rd-2011-2/)
- [American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort](https://scholariq.org/papers/american-college-of-rheumatology-classification-criteria-for-sjogren-s-syndrome/)
- [International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease](https://scholariq.org/papers/international-consensus-guidance-statement-on-the-management-and-treatment-of/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism/)
- [Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations](https://scholariq.org/papers/recommendations-for-the-nomenclature-of-igg4-related-disease-and-its-individual/)
- [A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details](https://scholariq.org/papers/a-novel-clinical-entity-igg4-related-disease-igg4rd-general-concept-and-details/)
- [A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details](https://scholariq.org/papers/a-novel-clinical-entity-igg4-related-disease-igg4rd-general-concept-and-details-2/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism-2/)
- [The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD](https://scholariq.org/papers/the-2020-revised-comprehensive-diagnostic-rcd-criteria-for-igg4-rd/)
- [Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders](https://scholariq.org/papers/proposal-for-a-new-clinical-entity-igg4-positive-multiorgan-lymphoproliferative/)

## Researcher topics

- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)
- [Gastrointestinal disorders and treatments](https://scholariq.org/topics/gastrointestinal-disorders-and-treatments/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Sphingolipid Metabolism and Signaling](https://scholariq.org/topics/sphingolipid-metabolism-and-signaling/)
- [Chemokine receptors and signaling](https://scholariq.org/topics/chemokine-receptors-and-signaling/)

## Researcher university

- [Nagahama City Hospital](https://scholariq.org/institutions/nagahama-city-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.